Flu shots still work against the most common winter strain

A Surprising Breakthrough in Flu Defense

Public health experts braced for disappointment when a new variant of the H3N2 flu virus emerged last season. With its slight genetic shifts, the updated virus threatened to evade the immunity provided by the previous year’s vaccine. Yet, against all expectations, the 2024/2025 shot continued to deliver robust protection—especially in adults. The findings, now confirmed by researchers, challenge assumptions about how quickly flu strains can outmaneuver our defenses.

Why the Old Vaccine Held Strong

Every flu season brings mutations, however minor. The virus subtly alters its outer proteins, making it harder for antibodies to recognize it. To counter this, vaccine formulations are typically revised annually. But this time, the older vaccine proved unexpectedly resilient. Experts speculate that the immune system’s ability to adapt played a key role—recognizing not just the exact strain but broader patterns in the virus’s structure.

A Season of Anomalies

The 2025/2026 flu season stood out for another reason: one dominant subclade of H3N2 circulated globally, a rarity compared to the usual mix of competing strains. Researchers are now investigating whether this uniformity contributed to the vaccine’s surprising success. Perhaps the dominant virus didn’t stray far enough from the vaccine’s target to slip past immunity entirely.

What Comes Next?

While the news is encouraging, scientists caution against overconfidence. Flu viruses remain unpredictable, and the next mutation could test these defenses anew. Still, the findings offer a glimmer of hope: even imperfect matches between vaccines and circulating strains can still provide meaningful protection.